Anti-GAD antibody-positive fulminant type 1 diabetes developed following SARS-CoV-2 vaccination.

Izumi, Tomohito; Takahashi, Hironobu; Takahashi, Hironori.

Afiliação

Izumi T; Division of Diabetes and Metabolism, Sendai City Hospital, 1-1-1 Asutonagamachi, Taihaku-Ku, Sendai, Miyagi 982-8502 Japan.
Takahashi H; Division of Diabetes and Metabolism, Sendai City Hospital, 1-1-1 Asutonagamachi, Taihaku-Ku, Sendai, Miyagi 982-8502 Japan.
Takahashi H; Division of Diabetes and Metabolism, Sendai City Hospital, 1-1-1 Asutonagamachi, Taihaku-Ku, Sendai, Miyagi 982-8502 Japan.

Diabetol Int ; 14(4): 422-426, 2023 Oct.

Article em En | MEDLINE | ID: mdl-37781472